News

Stay up to date on our latest stories.

Filters

Hikma launches Succinylcholine Chloride Injection, USP

Press Release, Product
Hikma launches Succinylcholine Chloride Injection, USP

Hikma launches Doxycycline for Injection

Press Release, Product
Hikma launches Doxycycline for Injection

Hikma launches Rufinamide Tablets

Press Release, Product
Hikma launches Rufinamide Tablets

Hikma launches Ganciclovir for Injection, USP

Press Release, Product
Hikma launches Ganciclovir for Injection, USP

REMINDER Branded Meet the Management 22 June 2021, 2:00pm to 3:00pm

Press Release, Corporate
REMINDER Branded Meet the Management 22 June 2021, 2:00pm to 3:00pm

Hikma appoints Patrick Genestin to lead Generics Business Development

Press Release, Corporate
Hikma appoints Patrick Genestin to lead Generics Business Development

Hikma launches Estradiol Valerate Injection, USP

Press Release, Product
Hikma launches Estradiol Valerate Injection, USP

Hikma launches Labetalol Hydrochloride Injection in ready-to-use bags

Press Release, Product
Hikma launches Labetalol Hydrochloride Injection in ready-to-use bags

Meet the Management Series – Branded

Press Release, Corporate
Meet the Management Series – Branded

Hikma launches Hydralazine Hydrochloride Injection, USP

Press Release, Product
Hikma launches Hydralazine Hydrochloride Injection, USP

Hikma launches Docetaxel Injection, USP

Press Release, Product
Hikma launches Docetaxel Injection, USP

Hikma launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Press Release, Product
Hikma launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Hikma announces good start to 2021 and reiterates full year guidance

Press Release, Corporate
Hikma announces good start to 2021 and reiterates full year guidance

Hikma announces US FDA approval of KLOXXADO TM (naloxone hydrochloride) nasal spray 8mg

Press Release, Corporate
Hikma announces US FDA approval of KLOXXADO TM (naloxone hydrochloride) nasal spray 8mg

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and ...

Press Release, Corporate
Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and ...